TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0

CUSIP: 88163VAE9

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Debt / DBCV 0.250% 2/0
Market price (% of par)
103.68%
Total 13F principal
$46,089,132
Principal change
-$807,000
Total reported market value
$47,806,000
Number of holders
4
Value change
-$836,624
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 88163VAE9?
CUSIP 88163VAE9 identifies 88163VAE9 - TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q3 2013

As of 30 Sep 2013, TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by 4 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $46,089,132 in principal (par value) of the bond. The largest 4 bondholders included VICTORY CAPITAL MANAGEMENT INC, LAZARD ASSET MANAGEMENT LLC, FLOSSBACH VON STORCH AG, and WELLS FARGO & COMPANY/MN. This page lists 4 institutional bondholders reporting positions for the Q3 2013 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.